Condition: Ovary Cancer · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
To evaluate if CT features at diagnosis in patients with HGSOC can be used to build an Artificial Intelligence model capable of discerning the pathological involvement of the mesentery, assessing the potential impediments for an optimal debulking surgery and predicting the development of resistance to platinum based chemotherapeutic agents.
This description comes directly from the study's public registry record.
Camilla Panico, Dr · +390630155701 · camilla.panico@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Advanced Radiology Center | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06331130